Views & analysis - Pharmaphorum

Trending

Latest Views & analysis

in Views & Analysis
Calliditas pushing on with kidney disease drug after IPO success
October 16, 2018 Share
X
Calliditas pushing on with kidney disease drug after IPO success
https://pharmaphorum.com/r-d/views-analysis-r-d/calliditas-pushing-kidney-disease-drug-ipo-success/
in Views and analysis
Digital health round-up: Pfizer appoints chief digital officer and more
October 12, 2018 Share
X
Digital health round-up: Pfizer appoints chief digital officer and more
https://pharmaphorum.com/views-and-analysis/digital-health-round-up-pfizer-appoints-chief-digital-officer-and-more/
in Disease Spotlight
Living with LHON: Blindness doesn’t mean losing sight of your dreams
October 11, 2018 Share
X
Living with LHON: Blindness doesn’t mean losing sight of your dreams
https://pharmaphorum.com/disease-spotlight/living-with-lhon-blindness-doesnt-mean-losing-sight-of-your-dreams/
in Digital
It’s time to get smart about blockchain in healthcare
October 10, 2018 Share
X
It’s time to get smart about blockchain in healthcare
https://pharmaphorum.com/digital/its-time-to-get-smart-about-blockchain-in-healthcare/

Living with LHON: Blindness doesn’t mean losing sight of your dreams

Living with LHON: Blindness doesn’t mean losing sight of your dreams

Losing your sight is every bookworm’s worst nightmare, but former English teacher Paula Morandi has not let her

X

Living with LHON: Blindness doesn’t mean losing sight of your dreams

https://pharmaphorum.com/disease-spotlight/living-with-lhon-blindness-doesnt-mean-losing-sight-of-your-dreams/

It’s time to get smart about blockchain in healthcare

It’s time to get smart about blockchain in healthcare

Healthcare data is everywhere and more is coming – data from wearables, data from Internet of Things devices,

X

It’s time to get smart about blockchain in healthcare

https://pharmaphorum.com/digital/its-time-to-get-smart-about-blockchain-in-healthcare/

Ahead of the curve

Ahead of the curve

Pharma often criticises the NHS for failing to adopt the latest therapies, arguing that NICE’s technology appraisals can

X

Ahead of the curve

https://pharmaphorum.com/views-analysis-oncology/ahead-curve-car-t/

Recommended authors

More Views & Analysis

Why pharma’s focus on patients requires less patience

Why pharma’s focus on patients requires less patience

Have you missed me? I certainly wouldn’t be so egotistical to assume that anyone has, but bizarrely it’s

X

Why pharma’s focus on patients requires less patience

https://pharmaphorum.com/patients/pharmas-focus-patients-requires-less-patience/

Digital health round-up – government and Sandoz recognise trailblazing projects

Digital health round-up – government and Sandoz recognise trailblazing projects

Richard Staines presents his weekly round-up of the latest digital health headlines

X

Digital health round-up – government and Sandoz recognise trailblazing projects

https://pharmaphorum.com/views-and-analysis/government-digital-health-catalyst/

Collaboration can ensure access to life-changing innovation

Collaboration can ensure access to life-changing innovation

As a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new

X

Collaboration can ensure access to life-changing innovation

https://pharmaphorum.com/views-analysis-market-access/access-life-changing-innovation-risk-sharing-scheme/

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

What can we learn from Batman and the Joker, the greatest hero/villain pairing of all time? Their co-dependent

X

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

https://pharmaphorum.com/r-d/views-analysis-r-d/art-storytelling-clinical-data-communication/

From graduate to chairman: My 30 years in pharma

From graduate to chairman: My 30 years in pharma

In today’s world, working at the same company for 30 years is increasingly rare. Yet, that’s exactly what

X

From graduate to chairman: My 30 years in pharma

https://pharmaphorum.com/sales-marketing/30_years_pharma_kris_sterkens/

A payer’s perspective on value-based contracting (VBC)

A payer’s perspective on value-based contracting (VBC)

What payer wouldn’t want to ensure that they pay for value when buying drugs? If the emerging trend

X

A payer’s perspective on value-based contracting (VBC)

https://pharmaphorum.com/views-analysis-market-access/payers-perspective-value-based-contracting-vbc/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com